comprehensive -WSS

comprehensive

author：focus 2025-10-01 17:19:48 - browse：2177

ANDREW YATES/AFP via Getty Images

WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare’s new drug price negotiation program.

Colm Connolly, chief judge of the U.S. District Court of Delaware, ruled against the company on all its major arguments. He wrote that AstraZeneca had not proved that Medicare’s new drug price negotiation program jeopardizes its constitutional property rights, and that the company didn’t have standing to challenge the guidance Medicare issued to implement the program.

The case is the first of a slew of cases filed by the pharmaceutical industry and its allies to be decided at the district court level. The Delaware ruling is a blow, as several of the other cases made similar arguments about how the program violates drugmakers’ constitutional property rights.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： How to use technology to prevent future drug shortages

WSS

The best solution to the drug shortages problem

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

American woman, child freed after being kidnapped in Haiti last month

With Wegovy coverage, Medicare patients may face high costs

Chinese researcher claims birth of first gene

knowledge

comprehensive

entertainment

The high cost of giving birth even with insurance

Steward Health Care expansion into Malta flopped

Apple is now the first public company to be valued at $3 trillion

Pfizer, Moderna say biotech, pharma drug development is a sprint

Medical leaders decry Supreme Court decision on affirmative action

6 surprising facts about sugar

Jerome Adams on the need for new antivirals for Covid

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

As demand for Covid shots wanes, Moderna seeks its next success

The best solution to the drug shortages problem

hotspot

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

American woman, child freed after being kidnapped in Haiti last month

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Bring on the sabbaticals for nurses

Cancer, immunology, HIV research ensnared in fetal tissue politics

hotspot

knowledge

focus

hotspot